Baricitinib in Pediatric Chronic Immune Thrombocytopenia and Associated Autoimmune Conditions: A Case Report

    December 2024 in “ Frontiers in Pediatrics
    G. López de Hontanar Torres, Josune Zubicaray, Elena Sebastián, Á. Hernández‐Martín, June Iriondo, Julián Sevilla
    Image of study
    TLDR Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.
    This case report highlights the successful use of baricitinib, a JAK 1/2 inhibitor, in a 16-year-old female with chronic immune thrombocytopenia (cITP) and alopecia areata, where conventional treatments failed. Baricitinib, used off-label, significantly improved platelet counts and alopecia, with sustained normal platelet levels post-treatment. The findings suggest baricitinib as a potential treatment for pediatric cITP with autoimmune conditions, warranting further clinical trials to validate its efficacy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 12 results

    Similar Research

    6 / 439 results